2 ASX shares liked by this top fund manager

Australian Clinical Labs is one of the ASX shares that is liked by WAM.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The fund manager Wilson Asset Management (WAM) has told investors about two ASX shares that it has in its portfolio.

WAM operates several listed investment companies (LICs). Some focus on larger companies like WAM Leaders Ltd (ASX: WLE).

There's also one called WAM Capital Limited (ASX: WAM) which targets "the most compelling undervalued growth opportunities in the Australian market."

The WAM Capital portfolio has delivered an investment return of 16.5% per annum since inception in August 1999, before fees, expenses and taxes. This gross return outperformed the S&P/ASX All Ordinaries Accumulation Index return of 8.7% per annum over the same timeframe.

These are the two ASX shares that WAM Capital outlined in its most recent monthly update:

asx investor daydreaming about US shares

Image source: Getty Images

Australian Clinical Labs Ltd (ASX: ACL)

WAM explained that Australian Clinical Labs is a healthcare business that provides pathology services in Australia. It has 86 accredited laboratories which provide services for more than 8 million people and 90 public and private hospitals.

The fund manager noted that the ASX share traded below its initial listing price after listing a few months ago. However, WAM reckons the market didn't understand its earnings power because the focus had been on automating systems and processes, coupled with increased levels of COVID-19 testing – the Australian Clinical Labs share price grew 14.1% during the month.

Why does WAM like the business now? It thinks the company will be able to increase its market share, which can be aided by earnings accretive acquisitions with its balance sheet.

The fund manager points out that Australian Clinical Labs was valued at an approximate 30% discount compared to its peers. This could change if the business can deliver the potential superior organic growth rates and successful acquisitions that WAM is expecting. This could lead to a re-rating of the business.

Select Harvests Limited (ASX: SHV)

The other ASX share that WAM currently likes is the leading almond producer Select Harvests. It is one of the largest growers in Australia.

WAM points out that Select Harvests has already benefited from "considerable growth" in Australian almond production and consumption in the last decade.

Australia is now the second biggest producer of almonds in the world, after the US.

One of the things that WAM noticed from a recent Select Harvests update was that there is growing demand for almonds with Australian almond exports up 67% on the prior period.

The almond business is also seeing higher market prices for its commodity. A downgrade of the US 2021 crop harvest is helping drive an increase in the overall market price for almonds by $0.50 per kilo to a range of $6.75 per kilo to $7.25 per kilo.

Wilson Asset Management believes that almond prices are set to stage a "multi-year recovery" which will help Select Harvests with its increased ownership of almond farms after the Piangil Orchard acquisition in October 2020.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »